Pharmaxis Investor Briefing - Clinical Trial Results | 24 May 2023
Release Date: 24/05/2023 12:00am
Pharmaxis Ltd (ASX: PXS) held an online investor briefing by chief executive officer Mr Gary Phillips on May 24 2023.
The event consisted of a short presentation on top line results of an investigator initiated phase 1c clinical trial in established scars, followed by a Q&A session from attendees.
Click here to view the presentation slides.
Categories: Video Content